Members |
targetComponentId |
CSF test due |
CSF test due |
CSF: [cell content] or [chloride] |
Cell count, cerebrospinal fluid |
CSF: angiotensin-converting enzyme level |
CSF: angiotensin-converting enzyme level |
CSF: angiotensin-converting enzyme level |
CSF: angiotensin-converting enzyme level |
CSF: chemical content -general |
Determination of general chemical content of cerebrospinal fluid (procedure) |
CSF: chloride &/or level) |
CSF chloride measurement |
CSF: chloride abnormal |
Cerebrospinal fluid chloride outside reference range |
CSF: chloride decreased |
Cerebrospinal fluid chloride below reference range |
CSF: chloride increased |
Cerebrospinal fluid chloride above reference range (finding) |
CSF: chloride normal |
Cerebrospinal fluid chloride within reference range (finding) |
CSF: electrophoresis |
CSF: electrophoresis |
CSF: electrophoresis abnormal |
Cerebrospinal fluid electrophoresis outside reference range (finding) |
CSF: electrophoresis normal |
Cerebrospinal fluid electrophoresis within reference range (finding) |
CSF: erythrocytosis |
CSF: erythrocytosis |
CSF: examination abnormal |
Cerebrospinal fluid examination abnormal (finding) |
CSF: examination normal |
CSF: examination normal |
CSF: globulin &/or level |
CSF globulin measurement |
CSF: globulin decreased |
Cerebrospinal fluid globulin below reference range (finding) |
CSF: globulin increased |
Cerebrospinal fluid globulin above reference range (finding) |
CSF: globulin normal |
Cerebrospinal fluid globulin within reference range |
CSF: glucose &/or level |
Glucose measurement, CSF |
CSF: glucose decreased |
Cerebrospinal fluid glucose below reference range |
CSF: glucose increased |
Cerebrospinal fluid glucose above reference range (finding) |
CSF: glucose normal |
Cerebrospinal fluid glucose within reference range |
CSF: lymphocytosis |
Cerebrospinal fluid lymphocytosis (finding) |
CSF: microorganisms |
Identification of microorganisms in CSF |
CSF: microorganisms seen |
CSF: microorganisms seen |
CSF: no microorganisms seen |
CSF: no microorganisms seen |
CSF: not examined |
CSF: not examined |
CSF: polymorph. leucocytosis |
CSF: polymorphonuclear leukocytosis |
CSF: protein &/or level |
Measurement of protein in cerebrospinal fluid specimen (procedure) |
CSF: protein - increased + |
Cerebrospinal fluid: protein - increased + |
CSF: protein - increased ++ |
Cerebrospinal fluid: protein - increased ++ |
CSF: protein normal |
Cerebrospinal fluid protein within reference range |
CT angiography of abdominal aorta |
CT angiography of abdominal aorta with contrast |
CT bone density |
CT bone density |
CT of abdomen |
CT of abdomen |
CT of brain |
CT of brain |
CT of chest |
CT of chest |
CT of dorsal region |
Computed tomography of back region (procedure) |
CT of face |
Computed tomography of face (procedure) |
CT of hip region structure |
CT of hip |
CT of knee region structure |
CT of knee |
CT of neck |
CT of neck |
CT of pelvic skeleton |
CT bony pelvis |
CT of pelvis |
CT of pelvis |
CT of skull |
CT of skull |
CVS examined - NAD |
CVS examined - NAD |
CVS not examined |
Cardiovascular system not examined |
Ca cervix - screening done |
Screening for malignant neoplasm of cervix done (situation) |
Ca cervix screen-no result yet |
Cancer cervix screen-no result yet |
Ca cervix screening - not needed |
Cancer cervix screening - not needed |
Ca cervix screening - not reached |
Cancer cervix screening - not reached |
Ca cervix screening - not wanted |
Screening for malignant neoplasm of cervix not wanted (situation) |
Ca cervix screening - up-to-date |
Cancer cervix screening - up-to-date (finding) |
Ca cervix screening abnormal |
Ca cervix screening abnormal (finding) |
Ca cervix screening and fee claim |
Cancer cervix screening and fee claim (finding) |
Ca cervix screening normal |
Ca cervix screening normal |
Ca in situ bladder (& papilloma) |
Carcinoma in situ of urinary bladder (disorder) |
Cabbage RAST test |
Cabbage specific IgE antibody measurement |
Cabergoline 0.5mg tablet |
Cabergoline 500 microgram oral tablet |
Cabinet maker |
Cabinetmaker |
Cable jointer |
Electric cable jointer |
Cacajao |
Genus Cacajao (organism) |
Cacao RAST test |
Cocoa specific IgE antibody measurement |
Cactus |
Family Cactaceae |
Cadaver allograft heart |
Allogeneic transplant heart (substance) |
Caecocystoplasty |
Cecocystoplasty |
Caesarean section |
Cesarean section |
Caesarean wound disruption |
Cesarean wound disruption (disorder) |
Caesarean wound disruption |
Cesarean wound disruption (disorder) |
Cafe-au-lait spots |
Café au lait spots |
Caffeine + ergotamine tartrate |
Product containing caffeine and ergotamine (medicinal product) |
Caffeine + ergotamine tartrate 100mg/1mg tablet |
Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet (clinical drug) |
Caffeine + ergotamine tartrate 100mg/2mg suppository (product) |
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
Caffeine intoxication |
Poisoning by caffeine |
Caffeine overdose of undetermined intent |
Caffeine overdose |
Caffeine poisoning of undetermined intent |
Poisoning by caffeine |
Caffeine-related disorder |
Caffeine-related disorder |
Café au lait spots |
Café au lait spots |
Caged-ball heart valve prosthesis |
Ball and cage cardiac valve prosthesis (physical object) |
Caisson disease |
Bends |
Calaband 7.5cmx6m bandage |
Zinc paste bandage |
Calcaneal region structure |
Heel structure (body structure) |
Calcarine fissure |
Calcarine sulcus |
Calcein |
Fluorexon stain (substance) |
Calciferol 1.25mg tablet |
Ergocalciferol 1.25 mg oral tablet |
Calciferol 250micrograms tablet |
Ergocalciferol 250 microgram oral tablet |
Calciferol binding protein |
GC globulin |
Calcific periarthritis |
Periarthritis |
Calcific tendinitis |
Calcific tendinitis |
Calcific tendinitis of shoulder |
Calcific tendinitis of shoulder |
Calcification of lens |
Calcified cataract |
Calcification of lung |
Calcification of lung |
Calcinosis |
Calcinosis |
Calcinosis, Raynaud's phenomenon, sclerodactyly, oesophageal dysfunction, telangiectasia syndrome |
CREST syndrome |
Calcinosis, Raynaud's phenomenon, sclerodactyly, oesophageal dysfunction, telangiectasia syndrome |
CREST syndrome |
Calcipotriene |
Product containing calcipotriol (medicinal product) |
Calcipotriene 0.005% ointment |
Product containing precisely calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Calcipotriene hydrate 0.005% cream |
Calcipotriol 50 microgram/g cutaneous cream |
Calcipotriol hydrate |
Calcipotriol monohydrate (substance) |